Advancing muscle aging and sarcopenia research through spatial transcriptomics

Area of Science:

• Gerontology
• Molecular Biology
• Muscle Physiology

Background:

• Sarcopenia, characterized by age-related decline in muscle mass and function, presents a major health concern.
• Multiple factors including cellular dysfunction, mitochondrial impairments, oxidative stress, and inflammation contribute to sarcopenia.
• Current therapeutic options for sarcopenia are limited, with ongoing development of pharmacological interventions.

Purpose of the Study:

• To review the current understanding of sarcopenia, its underlying mechanisms, and emerging therapeutic strategies.
• To highlight the application of spatial transcriptomics (ST) in sarcopenia research.
• To identify novel cellular and molecular targets for sarcopenia intervention using ST insights.

Main Methods:

• Review of existing literature on sarcopenia, muscle aging mechanisms, and therapeutic developments.
• Analysis of recent studies utilizing spatial transcriptomics (ST) to investigate skeletal muscle aging.
• Exploration of how ST data provides insights into spatial heterogeneity and cellular interactions in muscle atrophy.

Main Results:

• Advances in transcriptomics, particularly ST, have deepened the understanding of skeletal muscle aging.
• ST has revealed the spatial context of gene expression, uncovering site-specific regulation and cellular interactions.
• ST studies have identified novel cellular and molecular targets by examining the spatial heterogeneity of muscle aging and atrophy.

Conclusions:

• Spatial transcriptomics offers a powerful approach to dissect the complexities of sarcopenia.
• By integrating spatial information with muscle pathophysiology, ST can guide the development of targeted sarcopenia therapies.
• This approach holds significant promise for improving the health and quality of life for aging populations worldwide.